ebook Munafa Stock Market Course + Intraday & FNO calls  

       

NVO announcements Novo Nordisk A/s announcements and dividends declared USA

Novo Nordisk A/s Complete list of announcements declared & dividend announcements by Novo Nordisk A/s NVO

Novo Nordisk A/s NVO listed on USA and deals in Health Care Major Pharmaceuticals

Announcements and dividends declared by Novo Nordisk A/s NVO

Why Novo Nordisk Stock Flopped on Friday
A post-earnings price target raise on Novo Nordisk (NYSE: NVO) from an analyst couldn't overcome the drag of a executive's stock sale on Friday. Ultimately, investors ended up trading out of the Danish pharmaceutical company, sending its share price down b
Announcement as on 03 November 2023

Novo Nordisk gets approval to carry out clinical trials on weekly insulin
Novo Nordisk has received approval from the Drug Controller General of India to conduct phase-III studies for its new weekly insulin injection, IcoSema, in India. IcoSema is a combination of insulin and Semaglutide and is meant to control blood sugar level
Announcement as on 20 October 2023

: Novo Nordisk to buy hypertension treatment from for .3 billion from KBP Biosciences
Novo Nordisk A/S NVODK:NOVO.B said Monday it will pay .3 billion to KBP Biosciences to buy ocedurenone for uncontrolled hypertension. Ocedurenone is a pill that also has potential application for cardiovascular and kidney disease. The Denmark-based biote
Announcement as on 16 October 2023

Novo Nordisk (NVO) Raises Sales Outlook for 2023, Shares Gain
Novo Nordisk NVO upped its sales and operating profit forecast for 2023 yet again on the back of higher demand for diabetes drug Ozempic (semaglutide) and obesity drug Wegovy. 
Announcement as on 16 October 2023

: Novo Nordisk boosts sales and profit outlook, buoyed by Ozempic and Wegovy
Novo Nordisk NVO on Friday boosted its full-year 2023 profit and sales outlook, reflecting heightened expectations for Ozempic and Wegovy sales. The company now projects full-year sales growth of 32% to 38%, up from 27% to 33% previously, and operating pro
Announcement as on 13 October 2023

Announcements by Novo Nordisk A/s first page | Next page | Prev page |

NVO Novo Nordisk A/s current price & indicator signals

Moving Averages for Novo Nordisk A/s

  • 5Day Average: 48.57
  • 12Day Average: 48.44
  • 20Day Average: 48.12
  • 50Day Average: 50.05
  • 100Day Average: 52.59
  • 150Day Average: 58.44
  • 200Day Average: 61.22

NVO Indicators & signals

Indicator MACD (12,26,9)

48.43, 48.75, -0.46
Indicator MACD is in negative zone

Indicator ADX (14)

20.93, 20.61, 31.52
Indicator ADX is indicating that momentum is weak.
Momentum is towards selling.

Indicator RSI (14)

Current RSI is: 53
Indicator RSI is indicating buying momentum and stock might rise.

Recent prices of NVO Novo Nordisk A/s are as follows: Daily volume is divided by 10 day averaged volume

Date Close Range Change % Volume
19 Fri Dec 2025 48.11 46.84 to 48.80 1.03% 0.7 times
18 Thu Dec 2025 47.62 47.52 to 48.31 -0.31% 0.54 times
17 Wed Dec 2025 47.77 47.73 to 48.75 -2.43% 0.67 times
16 Tue Dec 2025 48.96 48.41 to 49.97 -2.8% 1.19 times
15 Mon Dec 2025 50.37 49.55 to 50.66 0.38% 0.96 times
12 Fri Dec 2025 50.18 49.92 to 50.75 -0.22% 1.04 times
11 Thu Dec 2025 50.29 49.59 to 50.54 2.53% 1.31 times
10 Wed Dec 2025 49.05 47.04 to 49.50 5.8% 1.43 times
09 Tue Dec 2025 46.36 46.08 to 46.79 -0.88% 0.86 times
08 Mon Dec 2025 46.77 46.35 to 47.17 -2.26% 1.25 times
05 Fri Dec 2025 47.85 47.83 to 49.15 -0.29% 0.76 times
04 Thu Dec 2025 47.99 46.84 to 48.24 0.88% 1.14 times

Videos related to: NVO announcements Novo Nordisk A/s announcements and dividends declared USA

Hindi Video Correct Way Of Fundamental Analysis Using EPS And PE - MunafaSutra

Hindi Video What Is Needed To Succeed In Stock Markets

NVO announcements Novo Nordisk A/s announcements and dividends declared USA

 

Back to top